1-1 of 1
Van Morris
Close
Sort by
Journal Articles

Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors

Elias Jabbour, Van Morris, Hagop Kantarjian, Cameron C. Yin, Elizabeth Burton, Jorge Cortes
Journal: Blood
Blood (2012) 120 (16): 3382–3383.
https://doi.org/10.1182/blood-2012-04-424192
Published: 2012